Discovered and characterized through a collaboration between Feng Zhang's lab and the NCBI, C2c2 opens up the RNA world to editing and other applications.
Its first client, Haystack Bio, will use Genecloud to analyze and store single-cell genomics data for a proprietary platform it is developing for the immunotherapy market.
Researchers led by MIT's Jim Collins have built upon their paper-based Ebola test and are hoping to find a partner to help scale production and manufacturing of the test.
The patent office has named the Broad Institute, et al. as the junior party in the proceedings and the University of California, et al. as the senior party.
By coupling a microfluidic platform and RNA sequencing, researchers found that single cells belonging to the same lineage have similar transcriptomic profiles.
